Abbott Laboratories (ABT)

USD 127.09

(2.08%)

Total Assets Summary of Abbott Laboratories

  • Abbott Laboratories's latest annual total assets in 2023 was 73.21 Billion USD , down -1.64% from previous year.
  • Abbott Laboratories's latest quarterly total assets in 2024 Q3 was - USD , up 1.83% from previous quarter.
  • Abbott Laboratories reported annual total assets of 74.43 Billion USD in 2022, down -1.01% from previous year.
  • Abbott Laboratories reported annual total assets of 75.19 Billion USD in 2021, up 3.65% from previous year.
  • Abbott Laboratories reported quarterly total assets of 72.46 Billion USD for 2024 Q1, down -1.02% from previous quarter.
  • Abbott Laboratories reported quarterly total assets of 73.01 Billion USD for 2024 Q2, up 0.76% from previous quarter.

Annual Total Assets Chart of Abbott Laboratories (2023 - 1989)

Historical Annual Total Assets of Abbott Laboratories (2023 - 1989)

Year Total Assets Total Assets Growth
2023 73.21 Billion USD -1.64%
2022 74.43 Billion USD -1.01%
2021 75.19 Billion USD 3.65%
2020 72.54 Billion USD 6.87%
2019 67.88 Billion USD 1.06%
2018 67.17 Billion USD -11.9%
2017 76.25 Billion USD 44.78%
2016 52.66 Billion USD 27.68%
2015 41.24 Billion USD -0.07%
2014 41.27 Billion USD -3.91%
2013 42.95 Billion USD -36.12%
2012 67.23 Billion USD 11.54%
2011 60.27 Billion USD 1.37%
2010 59.46 Billion USD 13.44%
2009 52.41 Billion USD 23.57%
2008 42.41 Billion USD 6.81%
2007 39.71 Billion USD 9.77%
2006 36.17 Billion USD 24.15%
2005 29.14 Billion USD 1.3%
2004 28.76 Billion USD 7.68%
2003 26.71 Billion USD 10.13%
2002 24.25 Billion USD 4.13%
2001 23.29 Billion USD 52.43%
2000 15.28 Billion USD 5.61%
1999 14.47 Billion USD 9.49%
1998 13.21 Billion USD 9.58%
1997 12.06 Billion USD 8.41%
1996 11.12 Billion USD 18.2%
1995 9.41 Billion USD 10.43%
1994 8.52 Billion USD 10.86%
1993 7.68 Billion USD 10.77%
1992 6.94 Billion USD 10.97%
1991 6.25 Billion USD 12.44%
1990 5.56 Billion USD 14.67%
1989 4.85 Billion USD 0.55%

Peer Total Assets Comparison of Abbott Laboratories

Name Total Assets Total Assets Difference
Allurion Technologies Inc. 71.71 Million USD -101994.489%
Artivion, Inc. 792.39 Million USD -9139.56%
Avanos Medical, Inc. 1.69 Billion USD -4226.046%
Butterfly Network, Inc. 304.27 Million USD -23961.865%
Butterfly Network, Inc. 304.27 Million USD -23961.865%
Bio-Rad Laboratories, Inc. 12.29 Billion USD -495.281%
Boston Scientific Corporation 35.13 Billion USD -108.373%
CONMED Corporation 2.3 Billion USD -3083.188%
Edwards Lifesciences Corporation 9.36 Billion USD -681.934%
Paragon 28, Inc. 340.69 Million USD -21389.35%
Glaukos Corporation 940.41 Million USD -7685.295%
Globus Medical, Inc. 5.08 Billion USD -1339.497%
Inspire Medical Systems, Inc. 676.81 Million USD -10717.496%
Integer Holdings Corporation 2.94 Billion USD -2388.027%
Medtronic plc 89.98 Billion USD 18.634%
Myomo, Inc. 14.58 Million USD -501999.637%
Nevro Corp. 635.71 Million USD -11416.832%
Owlet, Inc. 44.12 Million USD -165831.6%
Penumbra, Inc. 1.55 Billion USD -4604.348%
Vicarious Surgical Inc. 119.86 Million USD -60980.892%
Smith & Nephew plc 9.98 Billion USD -633.093%
Sonendo, Inc. 78.16 Million USD -93571.955%
STERIS plc 11.06 Billion USD -561.75%
Stryker Corporation 39.91 Billion USD -83.439%
Vapotherm, Inc. 77.61 Million USD -94227.274%
Zimmer Biomet Holdings, Inc. 21.49 Billion USD -240.579%